Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Otsuka/Lundbeck say brexpiprazole works in phase III trial

Otsuka/Lundbeck say brexpiprazole works in phase III trial On course as successor to antipsychotic Abilify. The first phase III data on Otsuka and Lundbeck's new antidepressant brexpiprazole is positive and will be presented at a conference in March, ... Abilify has already lost patent protection in a number of

Setback for Roche as schizophrenia candidate fails studies

Setback for Roche as schizophrenia candidate fails studies Abilify (aripiprazole) lost patent protection and succumbed to generic competition.

Ipragliflozin beats diabetes rivals to Japanese approval

Ipragliflozin beats diabetes rivals to Japanese approval 2010. - Otsuka Pharmaceutical has filed for approval of its once-monthly intramuscular formulation of antipsychotic Abilify (aripiprazole) as a maintenance treatment for schizophrenia. ... The product was launched in the US last year under the Abilify

Profits down at Lundbeck as revenues slip

Profits down at Lundbeck as revenues slip and depot antipsychotic Abilify Maintena (aripiprazole). ... Lundbeck said uptake of Abilify Maintena is "encouraging", although it did not break out sales figure for the drug, which reached the US market in March 2013 and has been recommended

Pharma deals during September 2013

Pharma deals during September 2013 Otsuka is focused on filling the gap to be left once its leading product antipsychotic blockbuster Abilify, comes off patent, imminently.

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics